Causal effects of methotrexate reductions/delays in treatment of high-grade resectable osteosarcoma

Authors :: Cristian Spitoni
Carlo Lancia
Hans Gelderblom
Marta Fiocco
Jakob K. Anninga
Source :: Journal of Clinical Oncology. 34:e22502-e22502
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e22502Background: We analyzed preoperative data from EURAMOS-1, a large study in resectable osteosarcoma where the regimen is MAP (Methotrexate/Adriamycin/Cisplatin), focusing on the effect on Hist...

Subjects :: musculoskeletal diseases
Cisplatin
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Causal effect
medicine.disease
Regimen
Internal medicine
Large study
Medicine
Osteosarcoma
Methotrexate
business
medicine.drug

Tools